Clinical Trial List

CLINICAL TRIAL LIST

Prospective Observational Study of Patients with Polycythemia Vera in US Clinical Practices (REVEAL)

CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

Randomized, Multicenter, Open-Label, Phase 3 Study of ACP-196 versus Obinutuzumab in Combination with Chlorambucil in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia.

BREAST CANCER

BREAST CA FOR NEUTROPENIA

A Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE).

TRIPLE NEGATIVE BREAST CA IN THE METASTATIC SETTING

A Randomized Multicenter Phase II Study of CDX-011 (CR011-vcMMAE) in Patients with Metastatic, GPNMB Over-Expressing, Triple Negative Breast Cancer.

OVARIAN CANCER

OVARIAN CANCER RELAPSED OR REFRACTORY

Phase III Randomized Clinical Trial of Lurbinectedin (PM01183) Versus Pegylated Liposomal Doxorubicin or Topotecan in Patients with Platinum-Resistant Ovarian Cancer.

MULTIPLE MYELOMA

RELAPSED MM

A phase 2 study of weekly 70mg/m2 Carfilomib with or without steroids for Multiple Myeloma patients refractory to 27mg/m2 Carfilzomib with or without steroids.

RELAPSED OR REFRACTORY MM

A phase 1/2 study of Pomalidomide as a replacement for Lenalidomide for Multiple Myeloma patients relapsed or refractory to a Lenalidomide-containing combination regimen.

What we offer

Services

Our Locations

Choose your preferred location

7320 Woodlake Avenue Suite 330, West Hills, CA 91307

818-346-1773

5620 Wilbur Avenue Suite 219, Tarzana, CA 91356

818-705-3900